SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 222 filers reported holding SHOCKWAVE MED INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,077,091 | -22.8% | 15,455 | +10.7% | 0.01% | -14.3% |
| Q2 2023 | $3,985,751 | +64.0% | 13,965 | +24.6% | 0.01% | +40.0% |
| Q1 2023 | $2,430,014 | +185.7% | 11,207 | +170.9% | 0.01% | +150.0% |
| Q4 2022 | $850,609 | +85.3% | 4,137 | +150.7% | 0.00% | +100.0% |
| Q3 2022 | $459,000 | +103.1% | 1,650 | +39.7% | 0.00% | – |
| Q2 2022 | $226,000 | -8.1% | 1,181 | -0.3% | 0.00% | – |
| Q1 2022 | $246,000 | +18.3% | 1,184 | +1.6% | 0.00% | – |
| Q4 2021 | $208,000 | -0.5% | 1,165 | +15.0% | 0.00% | – |
| Q3 2021 | $209,000 | -64.2% | 1,013 | -67.1% | 0.00% | -100.0% |
| Q2 2021 | $584,000 | +42.8% | 3,076 | -2.1% | 0.00% | 0.0% |
| Q1 2021 | $409,000 | +11.1% | 3,142 | -11.5% | 0.00% | 0.0% |
| Q4 2020 | $368,000 | +38.3% | 3,552 | +1.1% | 0.00% | 0.0% |
| Q3 2020 | $266,000 | +14.2% | 3,515 | -13.8% | 0.00% | 0.0% |
| Q2 2019 | $233,000 | – | 4,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |